All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness

By

Pocket Casts

15h ago· 2 min readen

Summary

Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussion covers China's regulatory reforms that accelerated this progress, the surge in novel drug development, and what the US would need to change to maintain competitiveness in biomedical innovation.

Source

Twitter / XChina's Rise in Global Clinical Trials: Regulatory Reforms and US Competitivenesspca.st

Key quotes

· 3 pulled
China's rapid rise to the top of global clinical trial output has been accelerated by significant regulatory reforms.
The surge in novel drug development in China represents a major shift in the global biomedical landscape.
The US would need to change several factors to stay competitive in biomedical innovation.
Snippet from the RSS feed
Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China’s progress, the…

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.